Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8243679 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 8 Pages |
Abstract
Conclusion: This study did not show a survival benefit of CCRT with weekly cisplatin and HDRICB for Stage II-III cervical cancer, nor did it demonstrate a significant increase of late complications when comparing with RT alone.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shang-Wen M.D., Ji-An M.D., Yao-Ching M.D., Lian-Shung M.D., Wei-Chun M.D., Wu-Chou M.D., Shih-Neng M.D., Fang-Jen M.D., Ph.D.,